Microbiome Sequencing Services Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2023-28

1
Global Microbiome Sequencing Services Market
Research and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Microbiome Sequencing Services Market
Research Report The latest report by IMARC,
titled Microbiome Sequencing Services Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2023-2028 " the global
microbiome sequencing services market reached a
value of US 1,846.3 Million in 2022.
Microbiome sequencing services assist in
evaluating microflora in human biota to
understand the function of microbes in human
health and disease pathogenesis. They utilize
next-generation sequencing (NGS) technologies to
analyze microorganisms growing on saliva, oral
mucosa, skin, conjunctiva, and gastrointestinal
tract. Microbiome sequencing services are widely
utilized for disease diagnosis and determining a
patients response to a specific treatment. As
compared to conventional microbiology methods,
microbiome sequencing is more cost-effective,
less labor-intensive, saves time, and provides
faster and more accurate classifications. It is
also capable of identifying low-abundant
bacteria, characterizing non-cultivable bacteria,
and profiling numerous microorganisms in a single
analysis. Request Free Sample Report
https//www.imarcgroup.com/microbiome-sequencing-s
ervices-market/requestsample
4
Report Description and Highlights
Report Description

Global Microbiome Sequencing Services Market
Trends The rising consumer awareness about the
advantages of early diagnosis and disease
detection is one of the key factors driving the
market growth. Microbiome sequencing services are
widely used to understand the relationship
between human pathogen and gut microbiome that
assist in determining the health status and
diagnosing infectious, inflammatory, immune, and
obesity-related diseases. In addition, the rising
prevalence of colorectal cancer (CRC) on account
of the increasing geriatric population,
proliferation of inflammatory intestinal
conditions, and widespread consumption of low
fiber and high-fat diet is acting as another
growth-inducing factor. Furthermore, recent
technological advancements in NGS, such as the
introduction of nanopore sequencing technology
and single-molecule real-time sequencing (SMRT)
methods that enhance data yield, reduce
amplification bias, and minimize costs, are
providing a considerable boost to the market
growth. Additionally, the integration of machine
learning (ML) and artificial intelligence (AI) to
interpret enormous microbiome data for improving
diagnostic accuracy and predicting diseases is
creating a positive outlook for the market.
Moreover, the significant growth in the
pharmaceutical industry and the increasing need
to study drug-microbiome interaction for
developing novel drugs, personalized medicines,
and biomarkers are providing an impetus to the
market growth. Other factors, including
increasing investments in microbiome research,
the significant development in the healthcare
industry, and the rising service adoption in
academia and research institutes for small
molecule and protein analysis, are anticipated to
drive the market growth. On account of the
aforementioned factors, the market value is
expected to reach US 5,568.4 Million by 2028,
exhibiting a CAGR of 20 during
2023-2028. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Technology
Sequencing by Synthesis (SBS) Sequencing
by Ligation (SBL) Pyrosequencing
Sanger Sequencing Others Breakup by
Research Type Outsourced Research
Internal Research Breakup by Laboratory Typ
e Dry Labs Wet Labs Breakup
by Application Shotgun Sequencing
Targeted Gene Sequencing

6
Report Description and Highlights
Report Description
RNA Sequencing Whole Genome Se
quencing Others Breakup by End User
Pharmaceutical and Biotechnology
Companies Research and Academic Institut
es Others Breakup by Region
North America United States
Canada Asia-Pacific
China Japan
India South Korea
Australia Indonesi
a

7
Report Description and Highlights
Report Description
Others Europe
Germany France
United Kingdom Italy
Spain Russia
Others Latin America
Brazil Mexico
Others Middle East and A
frica

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• BaseClear B.V. Clinical-Microbiomics A/S Diversige
  n Inc (OraSure Technologies Inc.)
  Mérieux NutriSciences Metabiomics Corporation (Bio
  Spherex LLC) Microbiome Insights Inc. Microbiome T
  herapeutics LLC Molecular Research LP Molzym GmbH
  Co. KG Resphera Biosciences LLC Shanghai Realbio
  Technology (RBT) Co. Ltd. Zymo Research Corporati
  on
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/microbiome-sequencing-s
  ervices-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us